메뉴 건너뛰기
Current Rheumatology Reports
Volumn 8, Issue 3, 2006, Pages 159-161
Antiphospholipid syndrome: What's new in understanding antiphospholipid antibody-related stroke?
Author keywords

[No Author keywords available]
Indexed keywords

ACETYLSALICYLIC ACID; CARDIOLIPIN ANTIBODY; CLOPIDOGREL; DIPYRIDAMOLE; PHOSPHOLIPID ANTIBODY; WARFARIN;
EID: 33747586502     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-996-0019-1     Document Type: Note
Times cited : (4)
References (7)
  • 1
    • 30444457880 scopus 로고    scopus 로고
    • Prevalence of antiphospholipid antibodies in patients with neurological symptoms
    • Miesbach W, Gilzinger A, Gokpinar B, et al.: Prevalence of antiphospholipid antibodies in patients with neurological symptoms. Clin Neurol Neurosurg 2006, 108:135-142.
    • (2006) Clin Neurol Neurosurg , vol.108 , pp. 135-142
    • Miesbach, W.1    Gilzinger, A.2    Gokpinar, B.3
  • 2
    • 27644592520 scopus 로고    scopus 로고
    • Antiphospholipid antibodies in young adults with stroke
    • Brey RL: Antiphospholipid antibodies in young adults with stroke. J Thromb Thrombolysis 2005, 20:105-112.
    • (2005) J Thromb Thrombolysis , vol.20 , pp. 105-112
    • Brey, R.L.1
  • 3
    • 24744445029 scopus 로고    scopus 로고
    • The impact of gender on clinical manifestations of primary antiphospholipid syndrome
    • Jara LJ, Medina G, Vera-Lastra O, Barile L: The impact of gender on clinical manifestations of primary antiphospholipid syndrome. Lupus 2005, 14:607-612.
    • (2005) Lupus , vol.14 , pp. 607-612
    • Jara, L.J.1    Medina, G.2    Vera-Lastra, O.3    Barile, L.4
  • 4
    • 20444504598 scopus 로고    scopus 로고
    • Valvular heart disease as a cause of cerebrovascular disease in patients with systemic lupus erythematosus
    • Roldan CA, Gelgand EA, Quails CR, Sibbitt WL Jr.: Valvular heart disease as a cause of cerebrovascular disease in patients with systemic lupus erythematosus. Am J Cardiol 2005, 95:1441-1447.
    • (2005) Am J Cardiol , vol.95 , pp. 1441-1447
    • Roldan, C.A.1    Gelgand, E.A.2    Quails, C.R.3    Sibbitt Jr., W.L.4
  • 5
    • 20444368056 scopus 로고    scopus 로고
    • Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: A prospective, long-term, followup study
    • Perez-Villa F, Font J, Azqueta M, et al.: Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, followup study. Arthritis Rheum 2005, 53:460-467.
    • (2005) Arthritis Rheum , vol.53 , pp. 460-467
    • Perez-Villa, F.1    Font, J.2    Azqueta, M.3
  • 6
    • 21344464939 scopus 로고    scopus 로고
    • Clinical characteristics of stroke patients with antiphospholipid antibodies
    • Terashi H, Uchiyama S, Hashimoto S, et al.: Clinical characteristics of stroke patients with antiphospholipid antibodies. Cerebrovasc Dis 2005, 19:384-390.
    • (2005) Cerebrovasc Dis , vol.19 , pp. 384-390
    • Terashi, H.1    Uchiyama, S.2    Hashimoto, S.3
  • 7
    • 13944263178 scopus 로고    scopus 로고
    • Anticoagulation and platelet antiaggregation therapy in stroke prevention
    • Chong JY, Mohr JP: Anticoagulation and platelet antiaggregation therapy in stroke prevention. Curr Opin Neurol 2005, 18:53-57.
    • (2005) Curr Opin Neurol , vol.18 , pp. 53-57
    • Chong, J.Y.1    Mohr, J.P.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.